Department of Obstetrics and Gynecology
New Taipei City, Taiwan
Location status: Recruiting
NCT Number: NCT05255289
The trans-obturator tape (TOT), which exhibits a satisfactory cure rate and a relatively diminished invasiveness, has been increasingly accepted as a surgical treatment of stress urinary incontinence (SUI) patients. Nevertheless, in contrast to the well-recognized therapeutic benefit of the enhanced resistance to the bladder continence during urine storage, if the voiding function of the bladder adapts to the TOT-enhanced outlet resistance has not been adequately investigated. This study retrospectively assayed the voiding efficacy of each voiding cycle, to clarify if the thermodynamic efficacy of the bladder was modified in response to the TOT surgery.
Interested in participating?
Request Info30 year–100 year
Female
Interventional
Not applicable
New Taipei City, Taiwan
Location status: Recruiting
The urodynamic study included free uroflowmetry, postvoid residual, filling and voiding cystometry, and a urethral pressure profile. The filling cystometry and urethral pressure profile were performed with 37 degrees C normal saline similar to body temperature at an infusion rate of 80 ml/min. All patients received a pre- and a post-operative urodynamic evaluation, in which pre-operative evaluation was conducted 1-4 weeks before TOT procedure, and post-operative evaluation was done at 4-6 weeks follow-up.
Complete multichannel urodynamic studies including free uroflowmetry, filling and voiding cystometry, and urethral pressure profile was performed in each patient. The urodynamic parameters measured were the maximum flow rate (Qmax), voided volume, post-void residual volume (PVR), and detrusor pressure at Qmax (Pdet. Qmax). The filling cystometry and urethral pressure profile were performed with 37 degrees C normal saline at an infusion rate of 80 ml/min. All data were recorded and analyzed using a Medical Measurement Systems (MMS UD-200, Enschede, The Netherlands). All data in this study will be expressed as mean ± SEM. After checking the normality and variance of data, two-way ANOVAs were used to assess the difference in values among testing groups and time points; and post hoc Student-Newman-Keuls tests were used to compare the means of groups when there was a significant difference between groups. Significance was set at p<0.05.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Urodynamic investigations (The urodynamic study included free uroflowmetry, postvoid residual, filling and voiding cystometry, and a urethral pressure profile. The filling cystometry and urethral pressure profile were performed with 37 degrees C normal saline similar to body temperature at an infusion rate of 80 ml/min.)
Urodynamic investigations (stated above.)
Urodynamic investigations (stated above)
Urodynamic investigations (stated above)
Urodynamic investigations (stated above.)
Time frame: within a voiding cycle (a cycle is about 30 to 60 minutes)
urine leakage.
Contact information is provided by the study sponsor or research team.
Mackay Medical College
Other
Evaluation of Efficacy and Safety of Midurethral Slings in Women With Stress Incontinence
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06161506
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Bethesda, Maryland, United States
View Trial DetailsNCT04133675
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Royal Oak, Michigan, United States
View Trial DetailsNCT04829175
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
New Haven, Connecticut, United States
View Trial DetailsNCT04829357
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
North Wales, Pennsylvania, United States
View Trial Details